Table 4. DPB1 supertype frequency in BCP ALL and non-BCP leukaemia compared with controls.
BCP ALL
|
Non-BCP leukaemia
|
|||||||
---|---|---|---|---|---|---|---|---|
DPB1 supertype | % | OR | 95% CI | P | % | OR | 95% CI | P |
DP2 (GEG) | 10.8 | 1.7 | 1.3–2.1 | <10−4* | 8.4 | 1.3 | 0.9–1.9 | 0.3 |
DP4 (GKG) | 60.0 | 1.1 | 0.9–1.2 | 0.27 | 57.9 | 0.9 | 0.8–1.2 | 1.0 |
DP6 (LED) | 6.2 | 1.2 | 0.9–1.6 | 0.24 | 8.9 | 1.8 | 1.2–2.7 | 0.007* |
DP3 (LKD) | 11.6 | 0.9 | 0.7–1.1 | 0.21 | 13.0 | 0.9 | 0.7–1.3 | 0.9 |
DP6 (GED) | 1.5 | 3.2 | 1.5–7.0 | 0.004* | 1.0 | 2.2 | 0.7–6.6 | 0.4 |
DP1 (GKD) | 6.4 | 0.5 | 0.4–0.7 | <10−5* | 8.4 | 0.7 | 0.5–1.1 | 0.1 |
Global χ2 | <10−6** | 0.04** | ||||||
Number= | 687 | 208 |
*Significant after correction for six supertypes.
**Significant (P<0.05) in global χ2 (CLUMP) analysis.